impact factor
logo
 

Letters to the Editor

 

Successful treatment of a patient with both systemic lupus erythematosus and progressive hepatitis C using immunosuppressive therapy and interferon beta


1, 2, 3, 4, 5, 6

 

  1. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  2. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan. hiroyuki_yjp2005@yahoo.co.jp
  3. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  4. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  5. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  6. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.

CER11083
2018 Vol.36, N°4
PI 0686
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 29745887 [PubMed]

Received: 06/01/2018
Accepted : 13/03/2018
In Press: 08/05/2018
Published: 19/07/2018

Rheumatology Article